An Investigation Into the Beneficial Effects of High-Dose Interferon beta 1-a, Compared to Low-Dose Interferon Beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19
Preprint
- 21 January 2021
- preprint
- Published by Research Square Platform LLC